CORE A: Patient Care Core The purpose of Core A is to coordinate and facilitate all the patient based research in this Program Project, arranging for patients to have selected tests at intervals that maximizes research testing while not disrupting the clinical care of any subject. This Core is responsible for arranging with patients convenient dates for appointments for clinical care, and organizing any research blood testing and obtaining samples for the laboratories of the participating investigators. Core A also coordinates the visits of patients pertinent to this program, who are traveling to Rockefeller Hospital so that blood or other samples can be shared with the investigative team. This Core also arranges for the submission of cells or other materials obtained, to the facilities of Core B, for cell phenotyping and/or cell isolation, and the establishment of cell lines as needed. This Core is responsible for obtaining cells, or other patient materials from outside sources as needed. This Core is also responsible for maintaining and updating all IRB and HIPAA materials and to obtain patient consents for all procedures. This Core will therefore continue to support Projects 1-4 in this ongoing Program Project.

Public Health Relevance

Patient Core A is required to coordinate patient recruitment while not impeding clinical care, so that research work is carried out under correct IRB protocols, confidentiality is maintained, and Project Leaders and other involved investigators and laboratories are aware of patients coming for clinic visits in a timely manner. Core A coordinates the collection of all materials obtained during clinic visits, or that are shipped, with Core B in a de-identified manner, in order to maximize'the use of all samples

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI061093-10
Application #
8525314
Study Section
Special Emphasis Panel (ZAI1-PA-I)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
10
Fiscal Year
2013
Total Cost
$63,894
Indirect Cost
$15,066
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Uzzan, Mathieu; Ko, Huaibin M; Mehandru, Saurabh et al. (2016) Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD). Curr Gastroenterol Rep 18:17
Chorny, Alejo; Casas-Recasens, Sandra; Sintes, Jordi et al. (2016) The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells. J Exp Med 213:2167-85
Massaad, Michel J; Zhou, Jia; Tsuchimoto, Daisuke et al. (2016) Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest 126:4219-4236
Scott, Eric M; Halees, Anason; Itan, Yuval et al. (2016) Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat Genet 48:1071-6
Cols, Montserrat; Rahman, Adeeb; Maglione, Paul J et al. (2016) Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency. J Allergy Clin Immunol 137:1206-1215.e6
Lee, Alison Joanne; Moncada-Vélez, Marcela; Picard, Capucine et al. (2016) Severe Mycobacterial Diseases in a Patient with GOF IκBα Mutation Without EDA. J Clin Immunol 36:12-5
Cantaert, Tineke; Schickel, Jean-Nicolas; Bannock, Jason M et al. (2016) Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint. J Clin Invest 126:4289-4302
Kuehn, Hye Sun; Boisson, Bertrand; Cunningham-Rundles, Charlotte et al. (2016) Loss of B Cells in Patients with Heterozygous Mutations in IKAROS. N Engl J Med 374:1032-43
Bonilla, Francisco A; Barlan, Isil; Chapel, Helen et al. (2016) International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract 4:38-59
Morbach, Henner; Schickel, Jean-Nicolas; Cunningham-Rundles, Charlotte et al. (2016) CD19 controls Toll-like receptor 9 responses in human B cells. J Allergy Clin Immunol 137:889-898.e6

Showing the most recent 10 out of 144 publications